Authors: Algenstaedt, P Hamann, A

Citation: P. Algenstaedt et A. Hamann, Glitazone, a new class of drugs in the treatment of type 2 diabetes, DEUT MED WO, 126(34-35), 2001, pp. 951-952

Authors: Hamann, A Brieske, C Tafel, J Buttron, P Schwarzloh, B Munzberg, H Hinney, A Mayer, H Siegfried, W Hebebrand, J Greten, H Algenstaedt, P Ziegler, R

Citation: A. Hamann et al., Identification of a deletion variant in the gene encoding the human alpha(2A)-adrenergic receptor, EUR J ENDOC, 144(3), 2001, pp. 291-295

Authors: Hamann, A Munzberg, H Algenstaedt, P Tafel, J

Citation: A. Hamann et al., Molecular basis of obesity, HERZ, 26(3), 2001, pp. 178-184

Authors: Ueki, K Algenstaedt, P Mauvais-Jarvis, F Kahn, CR

Citation: K. Ueki et al., Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85 alpha regulatory subunit, MOL CELL B, 20(21), 2000, pp. 8035-8046

Authors: Kausch, C Hamann, A Uphues, I Niendorf, A Muller-Wieland, D Joost, HG Algenstaedt, P Dreyer, M Rudiger, HW Haring, HU Eckel, J Matthaei, S

Citation: C. Kausch et al., Association of impaired phosphatidylinositol 3-kinase activity in GLUT1-containing vesicles with malinsertion of glucose transporters into the plasmamembrane of fibroblasts from a patient with severe insulin resistance and clinical features of Werner syndrome, J CLIN END, 85(2), 2000, pp. 905-918